Tweets by @tcochrane
-
New immunotherapy drug behind Jimmy Carter's cancer cure https://t.co/fG09FWYBrk -
From Brutish to a Brouhaha: Shifting Winds and the Demographic Payback https://t.co/LIOmt8lvYq via @RA_Insights
-
Vanguard’s Gain Is Wall Street’s Pain as Billions Leave the Financial Industry https://t.co/Q49H1S0IkT via @markets
-
New Approach Described for Eliminating Cancer Stem Cells | GEN News Highlights | GEN https://t.co/ercQ1HwADg via @genbio
-
The 403(b) lifetime income lesson for 401(k) plans https://t.co/PVb9mb1N2j
-
Immunology: Another shot at cancer https://t.co/vYiolqnmma
-
Immunotherapy for type 1 diabetes deemed safe in first US trial https://t.co/0lJVu6vpou via @medical_xpress
-
Antibody-drug compounds and immunotherapy to treat breast cancer https://t.co/PBIqSRilhg via @medical_xpress
-
Releasing CRISPR into the Wild Means No Turning Back https://t.co/kuvMCebv8m >@TechReview
-
The Revolutionary Gene-Editing Technique That Reveals Cancer’s Weaknesses https://t.co/A0Sn9lR1Ye
-
Israeli Billionaire Creates Arab Jobs and Questions Tech Culture https://t.co/Nmr0JGkCMw
-
Lloyd's Sees Blockchain's Potential For Insurance Markets https://t.co/cYiZ6Zuhyt via @CoinDesk
-
Will stem-cell grafts offer chicken soup for the ageing brain? — https://t.co/5OMQsZej0e via aeonmag
-
Cheap DNA Sequencing Is Here. Writing DNA Is Next https://t.co/ykEB2IddoG via @WIRED
-
Cigna Issues Coverage Criteria for Whole-Exome Sequencing; WGS Still Not Covered | GenomeWeb https://t.co/SSAgx6Fje6
-
Biohackers push life to the limits with DIY biology https://t.co/9FInULjObx
-
Terrorism in the Age of Twitter https://t.co/KupUQbgFYQ via @JohnCassidy
-
Symmetry is crucial to biology: a Q https://t.co/Ji8IGZaUh9 via @aeonmag
-
